Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection
Epstein Barr virus (EBV) exhibits a distinct tropism for both B cells and epithelial cells. The virus persists as a latent infection of memory B cells in healthy individuals, but a role for infection of normal epithelial is also likely. Infection of B cells is initiated by the interaction of the major EBV glycoprotein gp350 with CD21 on the B cell surface. Fusion is triggered by the interaction of the EBV glycoprotein, gp42 with HLA class II, and is thereafter mediated by the core fusion complex, gH/gL/gp42. In contrast, direct infection of CD21-negative epithelial cells is inefficient, but efficient infection can be achieved by a process called transfer infection. In this study, we characterise the molecular interactions involved in the three stages of transfer infection of epithelial cells: (i) CD21-mediated co-capping of EBV and integrins on B cells, and activation of the adhesion molecules, (ii) conjugate formation between EBV-loaded B cells and epithelial cells via the capped adhesion molecules, and (iii) interaction of EBV glycoproteins with epithelial cells, with subsequent fusion and uptake of virions. Infection of epithelial cells required the EBV gH and gL glycoproteins, but not gp42. Using an in vitro model of normal polarized epithelia, we demonstrated that polarization of the EBV receptor(s) and adhesion molecules restricted transfer infection to the basolateral surface. Furthermore, the adhesions between EBV-loaded B cells and the basolateral surface of epithelial cells included CD11b on the B cell interacting with heparan sulphate moieties of CD44v3 and LEEP-CAM on epithelial cells. Consequently, transfer infection was efficiently mediated via CD11b-positive memory B cells but not by CD11b–negative naïve B cells. Together, these findings have important implications for understanding the mechanisms of EBV infection of normal and pre-malignant epithelial cells in vivo.
Vyšlo v časopise:
Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection. PLoS Pathog 7(5): e32767. doi:10.1371/journal.ppat.1001338
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001338
Souhrn
Epstein Barr virus (EBV) exhibits a distinct tropism for both B cells and epithelial cells. The virus persists as a latent infection of memory B cells in healthy individuals, but a role for infection of normal epithelial is also likely. Infection of B cells is initiated by the interaction of the major EBV glycoprotein gp350 with CD21 on the B cell surface. Fusion is triggered by the interaction of the EBV glycoprotein, gp42 with HLA class II, and is thereafter mediated by the core fusion complex, gH/gL/gp42. In contrast, direct infection of CD21-negative epithelial cells is inefficient, but efficient infection can be achieved by a process called transfer infection. In this study, we characterise the molecular interactions involved in the three stages of transfer infection of epithelial cells: (i) CD21-mediated co-capping of EBV and integrins on B cells, and activation of the adhesion molecules, (ii) conjugate formation between EBV-loaded B cells and epithelial cells via the capped adhesion molecules, and (iii) interaction of EBV glycoproteins with epithelial cells, with subsequent fusion and uptake of virions. Infection of epithelial cells required the EBV gH and gL glycoproteins, but not gp42. Using an in vitro model of normal polarized epithelia, we demonstrated that polarization of the EBV receptor(s) and adhesion molecules restricted transfer infection to the basolateral surface. Furthermore, the adhesions between EBV-loaded B cells and the basolateral surface of epithelial cells included CD11b on the B cell interacting with heparan sulphate moieties of CD44v3 and LEEP-CAM on epithelial cells. Consequently, transfer infection was efficiently mediated via CD11b-positive memory B cells but not by CD11b–negative naïve B cells. Together, these findings have important implications for understanding the mechanisms of EBV infection of normal and pre-malignant epithelial cells in vivo.
Zdroje
1. RickinsonA
KieffE
2006 Fields Virology; DM K, PM H, eds. Philadelphia Lippincott Williams & Wilkins 2655 2700
2. NemerowGR
WolfertR
McNaughtonME
CooperNR
1985 Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55 347 351
3. FingerothJD
WeisJJ
TedderTF
StromingerJL
BiroPA
1984 Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A 81 4510 4514
4. LiQ
SpriggsMK
KovatsS
TurkSM
ComeauMR
1997 Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J Virol 71 4657 4662
5. MolesworthSJ
LakeCM
BorzaCM
TurkSM
Hutt-FletcherLM
2000 Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. J Virol 74 6324 6332
6. OdaT
ImaiS
ChibaS
TakadaK
2000 Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology 276 52 58
7. JiangR
GuX
NathanCO
Hutt-FletcherL
2008 Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells. J Oral Pathol Med 37 626 633
8. FeederleR
NeuhierlB
BannertH
GeletnekyK
Shannon-LoweC
2007 Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 121 588 594
9. TugizovSM
BerlineJW
PalefskyJM
2003 Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 9 307 314
10. ImaiS
NishikawaJ
TakadaK
1998 Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72 4371 4378
11. Shannon-LoweCD
NeuhierlB
BaldwinG
RickinsonAB
DelecluseHJ
2006 Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 103 7065 7070
12. TohyaK
UmemotoE
MiyasakaM
2010 Microanatomy of lymphocyte-endothelial interactions at the high endothelial venules of lymph nodes. Histol Histopathol 25 781 794
13. LiuY
ShawSK
MaS
YangL
LuscinskasFW
2004 Regulation of leukocyte transmigration: cell surface interactions and signaling events. J Immunol 172 7 13
14. HudnallSD
GeY
WeiL
YangNP
WangHQ
2005 Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18 519 527
15. Shannon-LoweC
BaldwinG
FeederleR
BellA
RickinsonA
2005 Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. J Gen Virol 86 3009 3019
16. Shannon-LoweC
AdlandE
BellAI
DelecluseHJ
RickinsonAB
2009 Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 83 7749 7760
17. DelecluseHJ
HilsendegenT
PichD
ZeidlerR
HammerschmidtW
1998 Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95 8245 8250
18. JanzA
OezelM
KurzederC
MautnerJ
PichD
2000 Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol 74 10142 10152
19. NeuhierlB
FeederleR
HammerschmidtW
DelecluseHJ
2002 Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A 99 15036 15041
20. DenekaM
Pelchen-MatthewsA
BylandR
Ruiz-MateosE
MarshM
2007 In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 177 329 341
21. Lottin-DivouxS
JeanD
Le RomancerM
FradeR
2006 Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav. Cell Signal 18 1219 1225
22. BarraultDV
KnightAM
2004 Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation. J Immunol 172 3509 3517
23. IanelliCJ
DeLellisR
Thorley-LawsonDA
1998 CD48 binds to heparan sulfate on the surface of epithelial cells. J Biol Chem 273 23367 23375
24. MeeCJ
GroveJ
HarrisHJ
HuK
BalfeP
2008 Effect of cell polarization on hepatitis C virus entry. J Virol 82 461 470
25. ZenK
LiuDQ
LiLM
ChenCX
GuoYL
2009 The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration. J Biol Chem 284 3768 3776
26. CalderwoodMA
VenkatesanK
XingL
ChaseMR
VazquezA
2007 Epstein-Barr virus and virus human protein interaction maps. Proc Natl Acad Sci U S A 104 7606 7611
27. BarelM
Le RomancerM
FradeR
2001 Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase. J Immunol 166 3167 3173
28. TessierJ
CuvillierA
GlaudetF
KhamlichiAA
2007 Internalization and molecular interactions of human CD21 receptor. Mol Immunol 44 2415 2425
29. PerryM
WhyteA
1998 Immunology of the tonsils. Immunol Today 19 414 421
30. PerryME
1994 The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat 185 Pt 1 111 127
31. DebertinAS
TschernigT
TonjesH
KleemannWJ
TrogerHD
2003 Nasal-associated lymphoid tissue (NALT): frequency and localization in young children. Clin Exp Immunol 134 503 507
32. LevyS
ToddSC
MaeckerHT
1998 CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16 89 109
33. AkiyamaSK
1996 Integrins in cell adhesion and signaling. Hum Cell 9 181 186
34. NguyenDH
GiriB
CollinsG
TaubDD
2005 Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304 559 569
35. KhunkaewlaP
SchillerHB
PasterW
LeksaV
CermakL
2008 LFA-1-mediated leukocyte adhesion regulated by interaction of CD43 with LFA-1 and CD147. Mol Immunol 45 1703 1711
36. JungeS
BrennerB
Lepple-WienhuesA
NiliusB
LangF
1999 Intracellular mechanisms of L-selectin induced capping. Cell Signal 11 301 308
37. ChigaevA
WallerA
AmitO
HalipL
BologaCG
2009 Real-time analysis of conformation-sensitive antibody binding provides new insights into integrin conformational regulation. J Biol Chem 284 14337 14346
38. Puklin-FaucherE
VogelV
2009 Integrin activation dynamics between the RGD-binding site and the headpiece hinge. J Biol Chem 284 36557 36568
39. DransfieldI
CabanasC
CraigA
HoggN
1992 Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol 116 219 226
40. ChesnokovaLS
NishimuraSL
Hutt-FletcherLM
2009 Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc Natl Acad Sci U S A 106 20464 20469
41. XuW
HeB
ChiuA
ChadburnA
ShanM
2007 Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol 8 294 303
42. FagarasanS
KinoshitaK
MuramatsuM
IkutaK
HonjoT
2001 In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature 413 639 643
43. Rodriguez-BoulanE
PowellSK
1992 Polarity of epithelial and neuronal cells. Annu Rev Cell Biol 8 395 427
44. ShinK
FoggVC
MargolisB
2006 Tight junctions and cell polarity. Annu Rev Cell Dev Biol 22 207 235
45. HadinotoV
ShapiroM
SunCC
Thorley-LawsonDA
2009 The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5 e1000496
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 5
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Crystal Structure and Functional Analysis of the SARS-Coronavirus RNA Cap 2′-O-Methyltransferase nsp10/nsp16 Complex
- The OXI1 Kinase Pathway Mediates -Induced Growth Promotion in Arabidopsis
- The Hexamer Structure of the Rift Valley Fever Virus Nucleoprotein Suggests a Mechanism for its Assembly into Ribonucleoprotein Complexes
- Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt